Back to Search Start Over

Translational validity and methodological underreporting in animal research: A systematic review and meta-analysis of the Fragile X syndrome (Fmr1 KO) rodent model.

Authors :
Kat R
Arroyo-Araujo M
de Vries RBM
Koopmans MA
de Boer SF
Kas MJH
Source :
Neuroscience and biobehavioral reviews [Neurosci Biobehav Rev] 2022 Aug; Vol. 139, pp. 104722. Date of Electronic Publication: 2022 Jun 08.
Publication Year :
2022

Abstract

Predictive models are essential for advancing knowledge of brain disorders. High variation in study outcomes hampers progress. To address the validity of predictive models, we performed a systematic review and meta-analysis on behavioural phenotypes of the knock-out rodent model for Fragile X syndrome according to the PRISMA reporting guidelines. In addition, factors accountable for the heterogeneity between findings were analyzed. The knock-out model showed good translational validity and replicability for hyperactivity, cognitive and seizure phenotypes. Despite low replicability, translational validity was also found for social behaviour and sensory sensitivity, but not for attention, aggression and cognitive flexibility. Anxiety, acoustic startle and prepulse inhibition phenotypes, despite low replicability, were opposite to patient symptomatology. Subgroup analyses for experimental factors moderately explain the low replicability, these analyses were hindered by under-reporting of methodologies and environmental conditions. Together, the model has translational validity for most clinical phenotypes, but caution must be taken due to low effect sizes and high inter-study variability. These findings should be considered in view of other rodent models in preclinical research.<br /> (Copyright © 2022 The Authors. Published by Elsevier Ltd.. All rights reserved.)

Details

Language :
English
ISSN :
1873-7528
Volume :
139
Database :
MEDLINE
Journal :
Neuroscience and biobehavioral reviews
Publication Type :
Academic Journal
Accession number :
35690123
Full Text :
https://doi.org/10.1016/j.neubiorev.2022.104722